CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

MMWRs by subject

Testing

Evaluation of Results from Occupational Tuberculin Skin Tests, Mississippi, 2006 — MMWR 2007; 56 (No. 50, 1316-1318)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5650a3.htm?s_cid=mm5650a3_e
PDF
Mycobacterium tuberculosis Transmission in a Newborn Nursery and Maternity Ward — New York City, 2003 — MMWR 2005; 54 (No. RR-50, 1280-1283)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5450a2.htm
PDF
Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States — MMWR 2005; 54 (No. RR-15, 49-55)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5415a4.htm
PDF
Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC — MMWR 2005; 54 (No. RR-15, 1-37)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5415a1.htm
PDF
Tuberculosis Associated with Blocking Agents Against Tumor Necrosis Factor - Alpha - California, 2002–2003 - MMWR 2004; 53 (No. 30)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a4.htm
PDF
Notice to Readers: Inadvertent Intradermal Administration of Tetanus Toxoid-Containing Vaccines Instead of Tuberculosis Skin Tests, MMWR 2004; 53 (No. 29)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5329a5.htm
PDF
Timing of Tuberculosis Screening and Smallpox Vaccination - Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program - MMWR 2003; 52 (No. RR-7)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5207a1.htm
PDF

Guidelines for Using the QuantiFERON-TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection. MMWR 2003:52(RR-2); 15-18
www.cdc.gov/mmwr/preview/mmwrhtml/rr5202a2.htm

PDF

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection - MMWR 2000; 49 (No. RR-6)
www.cdc.gov/mmwr/preview/mmwrhtml/rr4906a1.htm

PDF
Anergy Skin Testing and Preventive Therapy for HIV-Infected Persons: Revised Recommendations. - MMWR 1997; 46 (No. RR-15)
www.cdc.gov/mmwr/preview/mmwrhtml/00049386.htm
PDF
The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States. (ACET and ACIP - MMWR 1996; 45 (No. RR-4)
www.cdc.gov/mmwr/preview/mmwrhtml/00041047.htm
PDF
Self-Reported Tuberculin Skin Testing Among Indian Health Service and Federal Bureau of Prisons Dentists, 1993. - MMWR 1994; 43 (No. 11)
www.cdc.gov/mmwr/preview/mmwrhtml/00025841.htm
PDF
Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence. - MMWR 1993; 42 (No. RR-4)
www.cdc.gov/mmwr/preview/mmwrhtml/00023141.htm
PDF

 

Archived Testing

The documents listed below are historical, archived information. The information contained in these documents, while accurate at the time of release, may not be the most current available.

Guidelines for Using the QuantiFERON®-TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection - MMWR 2002; 51 (12/18/02)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5202a2.htm
PDF
Screening for Tuberculosis and Tuberculosis Infection in High-Risk Populations (ACET) - MMWR 1995; 44 (No. RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/00038873.htm
PDF

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333